Comcast Doesn't Doom Avandia Insurer Class, Judge Told

Law360, Philadelphia (March 14, 2014, 3:42 PM EDT) -- The U.S. Supreme Court’s Comcast Corp. v. Behrend decision does not bar class certification in a suit by two Humana Inc. units seeking damages from GlaxoSmithKline PLC for costs from treating certain Medicare patients allegedly harmed by the drug Avandia, a Pennsylvania federal judge heard Friday.

Richard Cohen, an attorney with Lowey Dannenberg Cohen & Hart PC representing the insurers, argued that his case dealt simply with claims that GSK violated its statutory requirement to reimburse Medicare Advantage organizations, or MAOs, for the cost of treating...
To view the full article, register now.